marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Ovid Therapeutics Bilanz 2011-2024 | OVID
Bilanz Jährlich Ovid Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-11 M | -28.3 M | - | -72 M | -41.9 M | -36.5 M | -87.1 M | -51.9 M | -69.9 M | - | - | - | - |
Langfristige Schulden |
14.8 M | 16 M | - | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
1.25 M | 534 K | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 10.2 M | 287 K | - | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
11.5 M | 6.99 M | 14.8 M | 22.1 M | 10.5 M | 8.84 M | 6.02 M | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
56.2 M | 23 M | 14.8 M | 32.3 M | 10.8 M | 8.84 M | 6.02 M | 3.73 M | 2.31 M | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | 2.21 M | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-278 M | -226 M | -171 M | -294 M | -213 M | -153 M | -101 M | -61.8 M | -13.5 M | - | - | - | - |
Vermögenswerte |
144 M | 155 M | 195 M | 75.9 M | 80.8 M | 47.6 M | 89.5 M | 53 M | 70.4 M | - | - | - | - |
Zahlungsmittel |
27 M | 44.9 M | 188 M | 72 M | 41.9 M | 36.5 M | 87.1 M | 51.9 M | - | - | - | - | - |
Buchwert |
87.8 M | 132 M | 180 M | 43.6 M | 70 M | 38.8 M | 83.4 M | 49.3 M | 68.1 M | - | - | - | - |
Gesamtes Eigenkapital |
87.8 M | 132 M | 180 M | 43.6 M | 70 M | 38.8 M | 83.4 M | 49.3 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Ovid Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
13.8 M | 14.1 M | 14.4 M | 14.8 M | 15.1 M | 15.4 M | 15.7 M | 16 M | 16.2 M | 16 M | 15.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
26.4 M | 29.2 M | 53.3 M | 56.2 M | 23.7 M | 25.5 M | 22.4 M | 23 M | 23 M | 25.2 M | 26.1 M | 14.8 M | 10.1 M | 11.3 M | 16.3 M | 32.3 M | 32.3 M | 32.3 M | 32.3 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 8.84 M | 8.84 M | 8.84 M | 8.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.21 M | 2.21 M | 2.21 M | 2.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-295 M | -281 M | -290 M | -278 M | -263 M | -251 M | -239 M | -226 M | -214 M | -202 M | -187 M | -171 M | -145 M | -134 M | -118 M | -294 M | -294 M | -294 M | -294 M | -213 M | -213 M | -213 M | -213 M | -153 M | -153 M | -153 M | -153 M | -101 M | -101 M | -101 M | -101 M | -35.9 M | -35.9 M | -35.9 M | -35.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
103 M | 118 M | 132 M | 144 M | 125 M | 136 M | 143 M | 155 M | 165 M | 177 M | 191 M | 195 M | 207 M | 218 M | 237 M | 75.9 M | 75.9 M | 75.9 M | 75.9 M | 80.8 M | 80.8 M | 80.8 M | 80.8 M | 47.6 M | 47.6 M | 47.6 M | 47.6 M | 89.5 M | 89.5 M | 89.5 M | 89.5 M | 53 M | 53 M | 53 M | 53 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
15 M | 29.7 M | 30.8 M | 27 M | 59.4 M | 73.6 M | 65 M | 44.9 M | 60.2 M | 74.7 M | 169 M | 188 M | 202 M | 212 M | 233 M | 72 M | 72 M | 72 M | 72 M | 41.9 M | 41.9 M | 41.9 M | 41.9 M | 36.5 M | 36.5 M | 36.5 M | 36.5 M | 87.1 M | 87.1 M | 87.1 M | 87.1 M | 51.9 M | 51.9 M | 51.9 M | 51.9 M | 69.9 M | - | - | - | 4.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
76.3 M | 88.9 M | 78.3 M | 87.8 M | 101 M | 111 M | 121 M | 132 M | 142 M | 152 M | 165 M | 180 M | 197 M | 207 M | 221 M | 43.6 M | 43.6 M | 43.6 M | 43.6 M | 70 M | 70 M | 70 M | 70 M | 38.8 M | 38.8 M | 38.8 M | 38.8 M | 89.5 M | 89.5 M | 89.5 M | 89.5 M | 53 M | 53 M | 53 M | 53 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
76.3 M | 88.9 M | 78.3 M | 87.8 M | 101 M | 111 M | 121 M | 132 M | 142 M | 152 M | 165 M | 180 M | 197 M | 207 M | 221 M | 43.6 M | 43.6 M | 43.6 M | 43.6 M | 70 M | 70 M | 70 M | 70 M | 38.8 M | 38.8 M | 38.8 M | 38.8 M | 83.4 M | 83.4 M | 83.4 M | 83.4 M | 49.3 M | 49.3 M | 49.3 M | 49.3 M | 68.1 M | - | - | - | 4.74 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung